tradingkey.logo


tradingkey.logo


Fresenius Medical Care AG

FMS
23.060USD
+0.315+1.38%
終倀 01/09, 16:00ET15分遅れの株䟡
6.68B時䟡総額
16.96盎近12ヶ月PER


Fresenius Medical Care AG

23.060
+0.315+1.38%

詳现情報 Fresenius Medical Care AG 䌁業名

Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD) and offers other extracorporeal therapies, as well as other healthcare services. It has two operating segments such as care delivery segment which consolidates the global health care services business and care enablement segment includes research and development (R&D), manufacturing, supply chain, and commercial operations. It develops and manufactures health care products, which includes dialysis and non-dialysis products. Such as hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals, and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. It owns, operates, or manages dialysis clinics sells products to other dialysis providers.

Fresenius Medical Care AGの䌁業情報


䌁業コヌドFMS
䌚瀟名Fresenius Medical Care AG
䞊堎日Oct 02, 1996
最高経営責任者「CEO」Cordola (Craig)
埓業員数111513
蚌刞皮類Depository Receipt
決算期末Oct 02
本瀟所圚地Else-Kroener-Strasse 1
郜垂BAD HOMBURG VOR DER HOHE
蚌刞取匕所NASDAQ OMX NASDAQ Basic NYSE
囜Germany
郵䟿番号61352
電話番号4961726090
りェブサむトhttps://www.freseniusmedicalcare.com/
䌁業コヌドFMS
䞊堎日Oct 02, 1996
最高経営責任者「CEO」Cordola (Craig)

Fresenius Medical Care AGの経営陣


䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Ms. Pascale Witz
Ms. Pascale Witz
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Dr. Dominik Heger
Dr. Dominik Heger
Head of Investor Relations, Strategic Development and Communications, EVP
Head of Investor Relations, Strategic Development and Communications, EVP
--
--
Dr. Katarzyna Mazur-Hofsaess
Dr. Katarzyna Mazur-Hofsaess
Member of the Management Board, Chief Executive Officer - Care Enablement
Member of the Management Board, Chief Executive Officer - Care Enablement
--
--
Dr. Frank W. Maddux, M.D.
Dr. Frank W. Maddux, M.D.
Member of the Management Board, Global Chief Medical Officer
Member of the Management Board, Global Chief Medical Officer
--
--
Ms. Helen Giza
Ms. Helen Giza
Chairman of the Management Board, Chief Executive Officer
Chairman of the Management Board, Chief Executive Officer
--
--
Mr. A. Gregory Sorensen, M.D.
Mr. A. Gregory Sorensen, M.D.
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Mr. Martin Fischer
Mr. Martin Fischer
Chief Financial Officer, Member of the Management Board
Chief Financial Officer, Member of the Management Board
--
--
Mr. Craig Cordola, Ed.D.
Mr. Craig Cordola, Ed.D.
Member of the Management Board, Chief Executive Officer - Care Delivery
Member of the Management Board, Chief Executive Officer - Care Delivery
--
--
Mr. Michael Sen
Mr. Michael Sen
Chairman of the Supervisory Board
Chairman of the Supervisory Board
--
--
Mr. Shervin J. Korangy
Mr. Shervin J. Korangy
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
詳现を芋る
䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Ms. Pascale Witz
Ms. Pascale Witz
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Dr. Dominik Heger
Dr. Dominik Heger
Head of Investor Relations, Strategic Development and Communications, EVP
Head of Investor Relations, Strategic Development and Communications, EVP
--
--
Dr. Katarzyna Mazur-Hofsaess
Dr. Katarzyna Mazur-Hofsaess
Member of the Management Board, Chief Executive Officer - Care Enablement
Member of the Management Board, Chief Executive Officer - Care Enablement
--
--
Dr. Frank W. Maddux, M.D.
Dr. Frank W. Maddux, M.D.
Member of the Management Board, Global Chief Medical Officer
Member of the Management Board, Global Chief Medical Officer
--
--
Ms. Helen Giza
Ms. Helen Giza
Chairman of the Management Board, Chief Executive Officer
Chairman of the Management Board, Chief Executive Officer
--
--
Mr. A. Gregory Sorensen, M.D.
Mr. A. Gregory Sorensen, M.D.
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--

収益内蚳

通貚: USD曎新時刻: Tue, Jan 6
通貚: USD曎新時刻: Tue, Jan 6
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
䌚瀟から関連デヌタがただ開瀺されおいたせん。
地域別USD
䌚瀟名
収益
比率
North America
14.78B
70.68%
Rest of the world
5.61B
26.84%
Germany
518.03M
2.48%
事業別
地域別
䌚瀟から関連デヌタがただ開瀺されおいたせん。

株䞻

曎新時刻: Sun, Nov 16
曎新時刻: Sun, Nov 16
株䞻統蚈
皮類
株䞻統蚈
株䞻統蚈
比率
Pzena Investment Management, LLC
2.56%
Wellington Management Company, LLP
1.42%
Fiduciary Management, Inc.
0.94%
Dodge & Cox
0.66%
Todd Asset Management LLC
0.22%
他の
94.20%
株䞻統蚈
株䞻統蚈
比率
Pzena Investment Management, LLC
2.56%
Wellington Management Company, LLP
1.42%
Fiduciary Management, Inc.
0.94%
Dodge & Cox
0.66%
Todd Asset Management LLC
0.22%
他の
94.20%
皮類
株䞻統蚈
比率
Investment Advisor/Hedge Fund
5.15%
Investment Advisor
2.13%
Hedge Fund
0.35%
Research Firm
0.25%
Pension Fund
0.14%
Family Office
0.02%
Bank and Trust
0.01%
他の
91.95%

機関投資家保有株


曎新時刻: Mon, Dec 8
曎新時刻: Mon, Dec 8
報告期間
機関投資家数
保有株匏数
比率
倉動額
2025Q4
346
46.58M
8.04%
-2.99M
2025Q3
337
47.00M
8.12%
-7.47K
2025Q2
350
47.02M
8.22%
+2.00M
2025Q1
348
45.04M
8.08%
-2.40M
2024Q4
337
43.94M
8.01%
+456.34K
2024Q3
325
43.49M
7.70%
+2.26M
2024Q2
343
41.23M
8.48%
-1.66M
2024Q1
362
42.90M
8.31%
-5.86M
2023Q4
362
42.80M
8.39%
+76.36K
2023Q3
367
42.72M
8.58%
-1.02M
詳现を芋る

株䞻動向


䌚瀟名
保有株匏数
比率
倉動額
倉動率
日付
Pzena Investment Management, LLC
14.82M
2.56%
+153.87K
+1.05%
Sep 30, 2025
Wellington Management Company, LLP
8.20M
1.42%
--
--
Sep 30, 2025
Fiduciary Management, Inc.
5.46M
0.94%
-198.98K
-3.52%
Sep 30, 2025
Dodge & Cox
3.83M
0.66%
--
--
Sep 30, 2025
Todd Asset Management LLC
1.30M
0.22%
+64.31K
+5.19%
Sep 30, 2025
Aristotle Capital Management, LLC
1.13M
0.2%
-7.00K
-0.61%
Sep 30, 2025
Parametric Portfolio Associates LLC
985.01K
0.17%
+12.65K
+1.30%
Sep 30, 2025
Morgan Stanley & Co. International Plc
908.00K
0.16%
-350.00K
-27.82%
Sep 30, 2025
Janus Henderson Investors
829.14K
0.14%
+300.92K
+56.97%
Jun 30, 2025
Kentucky Teachers' Retirement System
816.20K
0.14%
+62.70K
+8.32%
Sep 30, 2025
詳现を芋る

関連ETF


曎新時刻: Sat, Dec 6
曎新時刻: Sat, Dec 6
銘柄名
比率
Cultivar ETF
1.01%
ActivePassive International Equity ETF
0.08%
Avantis Responsible International Equity ETF
0.06%
Avantis International Equity ETF
0.01%
Pacer Developed Markets International Cash Cws 100
0%
Unusual Whales Subversive Democratic Trading ETF
0%
DFA Dimensional International Core Equity 2 ETF
0%
SGI Enhanced Global Income ETF
0%
Unusual Whales Subversive Republican Trading ETF
0%
The Opal International Dividend Income ETF
0%
詳现を芋る
Cultivar ETF
比率1.01%
ActivePassive International Equity ETF
比率0.08%
Avantis Responsible International Equity ETF
比率0.06%
Avantis International Equity ETF
比率0.01%
Pacer Developed Markets International Cash Cws 100
比率0%
Unusual Whales Subversive Democratic Trading ETF
比率0%
DFA Dimensional International Core Equity 2 ETF
比率0%
SGI Enhanced Global Income ETF
比率0%
Unusual Whales Subversive Republican Trading ETF
比率0%
The Opal International Dividend Income ETF
比率0%

配圓金


過去5幎間の配圓金総支払額は 1.59B 米ドルである。
日付
配圓金
暩利確定日
支払日
配圓萜ち日
May 07, 2025
FMS.NB Final Cash Dividend of gross USD 0.814968 paid on Jun 06, 2025 going ex on May 23, 2025
May 23, 2025
Jun 06, 2025
May 23, 2025
Apr 15, 2024
FMS.NB Final Cash Dividend of gross USD 0.642838 paid on Jun 03, 2024 going ex on May 17, 2024
May 20, 2024
Jun 03, 2024
May 17, 2024
May 03, 2023
FMS.NB Final Cash Dividend of gross USD 0.604856 paid on Jun 01, 2023 going ex on May 17, 2023
May 18, 2023
Jun 01, 2023
May 17, 2023
Apr 28, 2022
FMS.NB Final Cash Dividend of gross USD 0.708547 paid on May 27, 2022 going ex on May 13, 2022
May 16, 2022
May 27, 2022
May 13, 2022
May 16, 2021
FMS.NB Final Cash Dividend of gross USD 0.819276 paid on Jun 07, 2021 going ex on May 24, 2021
May 25, 2021
Jun 07, 2021
May 24, 2021
Aug 12, 2020
FMS.NB Final Cash Dividend of gross USD 0.71688 paid on Sep 11, 2020 going ex on Aug 28, 2020
Aug 31, 2020
Sep 11, 2020
Aug 28, 2020

株匏分割


日付
皮類
比率
デヌタなし
日付
皮類
比率
デヌタなし

よくある質問

Fresenius Medical Care AGの䞊䜍5名の株䞻は誰ですか


Fresenius Medical Care AGの䞊䜍5名の株䞻は以䞋のずおりです。
Pzena Investment Management, LLCは14.82M株を保有しおおり、これは党䜓の2.56%に盞圓したす。
Wellington Management Company, LLPは8.20M株を保有しおおり、これは党䜓の1.42%に盞圓したす。
Fiduciary Management, Inc.は5.46M株を保有しおおり、これは党䜓の0.94%に盞圓したす。
Dodge & Coxは3.83M株を保有しおおり、これは党䜓の0.66%に盞圓したす。
Todd Asset Management LLCは1.30M株を保有しおおり、これは党䜓の0.22%に盞圓したす。

Fresenius Medical Care AGの株䞻タむプ䞊䜍3皮は䜕ですか


Fresenius Medical Care AGの株䞻タむプ䞊䜍3皮は、
Pzena Investment Management, LLC
Wellington Management Company, LLP
Fiduciary Management, Inc.

Fresenius Medical Care AGFMSの株匏を保有しおいる機関の数はいく぀ですか


2025Q4時点で、Fresenius Medical Care AGの株匏を保有しおいる機関は346瀟あり、保有株匏の総垂堎䟡倀は玄46.58Mで、党䜓の8.04%を占めおいたす。2025Q3ず比范しお、機関の持ち株は-0.08%増加しおいたす。

Fresenius Medical Care AGの最倧の収益源は䜕ですか


FY2024においお、--郚門がFresenius Medical Care AGにずっお最倧の収益を生み出しおおり、その金額は--で、党収益の--%を占めおいたす。
KeyAI
î™